US BANCORP \DE\ - PDS BIOTECHNOLOGY CORP ownership

PDS BIOTECHNOLOGY CORP's ticker is PDSB and the CUSIP is 70465T107. A total of 69 filers reported holding PDS BIOTECHNOLOGY CORP in Q1 2023. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of PDS BIOTECHNOLOGY CORP
ValueSharesWeighting
Q2 2023$10,483
-18.2%
2,0840.0%0.00%
Q1 2023$12,817
-53.4%
2,0840.0%0.00%
Q4 2022$27,509
+358.5%
2,0840.0%0.00%
Q3 2022$6,000
+50.0%
2,084
+92.3%
0.00%
Q2 2022$4,0001,0840.00%
Other shareholders
PDS BIOTECHNOLOGY CORP shareholders Q1 2023
NameSharesValueWeighting ↓
INSPIRION WEALTH ADVISORS, LLC 330,874$1,670,9140.33%
TANG CAPITAL MANAGEMENT LLC 400,000$2,020,0000.28%
AMUSSEN HUNSAKER ASSOCIATES LLC 75,016$377,3300.08%
Nebula Research & Development LLC 25,708$129,8250.07%
Corton Capital Inc. 22,091$111,5600.06%
Sofinnova Investments, Inc. 142,635$720,3070.04%
LAZARI CAPITAL MANAGEMENT, INC. 11,000$55,5500.03%
OCCUDO QUANTITATIVE STRATEGIES LP 24,369$123,0630.02%
WINTON GROUP Ltd 21,256$107,3430.01%
Truvestments Capital LLC 1,372$6,9290.00%
View complete list of PDS BIOTECHNOLOGY CORP shareholders